The Journal of Organic Chemistry
Article
General Procedure for the Coupling of Organozinc Reagents
with Bromosugar 5 (Procedure A). A dry, argon-flushed 50 mL flask
was charged with the corresponding iodoarene (6.4 mmol),
tetradecane (2.5 mmol) as internal standard, and anhydrous toluene
(25 mL). n-BuLi (6.7 mmol, 1.05 equiv) was slowly added dropwise
at −10 °C, and then the reaction was allowed to warm to 0 °C.17 The
reaction was monitored at this temperature until samples quenched
with MeOH showed full iodine−lithium exchange by HPLC analysis.
Subsequently, a solution of ZnBr2·LiBr in (nBu)2O (0.55 or 1.05
equiv) was added dropwise, and the reaction mixture was heated
slowly to 60 °C.18 Bromosugar 5 (1.0 equiv)19 was added in one
portion, and the reaction mixture was heated to 85 °C and stirred
until full conversion was achieved. Reactions were monitored by GC
(quantitative) and HPLC (qualitative) analysis. Two solutions were
prepared each time: the first one by quenching a sample of the
reaction with an aqueous solution of NH4Cl solution. A second
sample was quenched with a solution of I2 in MTBE followed by aq
sodium sulfite treatment. In both cases, only the organic layer was
analyzed. Upon full conversion of one of the reactants, the reaction
was quenched with a sat. aqueous NH4Cl, and the organic layer was
quantitatively analyzed by GC.
126.7, 126.5, 80.8, 76.4, 73.5, 71.8, 67.7, 61.6, 38.6, 38.52, 38.5, 38.3,
27.0, 26.91, 26.88, 26.7. HRMS (EI) calcd for [C38H52O9 + H]
653.3684, found 653.3679.
2,3,4,6-Tetra-O-pivaloyl 1-(Biphenyl-4-yl)-1-deoxy-β-D-glucopyr-
1
anose (α-para-21). H NMR (300 MHz, CDCl3): δ 7.59 (d, J =
8.3 Hz, 2H), 7.51 (d, J = 5.8 Hz, 2H), 7.48 (d, J = 5.1 Hz, 2H), 7.34
(t, J = 7.4 Hz, 2H), 7.24 (t, J = 7.2 Hz, 1H), 5.77−5.59 (m, 1H),
5.34−5.31 (m, 2H), 5.08 (t, J = 9.3 Hz, 1H), 4.02−3.89 (m, 2H),
3.55 (ddd, J = 9.6, 5.2, 2.4 Hz, 1H), 1.09 (s, 9H), 1.07 (s, 9H), 1.02
(s, 9H), 0.95 (s, 9H). 13C{1H} NMR (75 MHz, CDCl3): δ 178.0,
177.3, 177.0, 176.6, 141.0, 140.2, 134.3, 129.1, 128.8, 127.6, 127.1,
127.0, 73.5, 71.1, 70.4, 70.1, 68.6, 62.3, 38.8, 38.74, 38.68, 27.2, 27.1,
27.0. HRMS (EI) calcd for [C38H52O9 + H] 653.3684, found
653.3683.
2,3,4,6-Tetra-O-pivaloyl 1-(Biphenyl-4-yl)-1-deoxy-β-D-glucopyr-
1
anose (β-para-21). H NMR (300 MHz, CDCl3): δ 7.52−7.44 (m,
4H), 7.39−7.31 (m, 4H), 7.26 (t, J = 7.2 Hz, 1H), 5.39 (t, J = 9.3 Hz,
1H), 5.29 (t, J = 9.5 Hz, 1H), 5.24 (t, J = 9.5 Hz, 1H), 4.39 (d, J =
9.7 Hz, 1H), 4.16 (dd, J = 12.4, 1.6 Hz, 1H), 4.07 (dd, J = 12.5, 3.9
Hz, 1H), 3.81 (ddd, J = 9.7, 3.5, 1.6 Hz, 1H), 1.16 (s, 9H), 1.10 (s,
9H), 1.05 (s, 10H), 0.82 (s, 9H). 13C{1H} NMR (75 MHz, CDCl3):
δ 178.0, 177.3, 176.3, 176.0, 141.8, 140.5, 135.1, 128.7, 128.2, 127.4,
127.0, 80.7, 76.6, 73.7, 72.0, 67.9, 61.8, 38.8, 38.71, 38.67, 38.5, 27.14,
27.07, 27.0, 26.9. HRMS (EI) calcd for [C38H52O9 + H] 653.3684,
found 653.3681.
Yields and ratios obtained with the different substrates are reported
in Tables 1−3.
2,3,4,6-Tetra-O-pivaloyl 1-(2-Anisyl)-1-deoxy-β-D-glucopyranose
(β-ortho-6). The NMR spectral data match published data.3a
2,3,4,6-Tetra-O-pivaloyl 1-(4-Anisyl)-1-deoxy-β-D-glucopyranose
(β-meta-6). 1H NMR (300 MHz, CDCl3): δ 7.22 (t, J = 7.9 Hz, 1H),
6.91 (d, J = 7.8 Hz, 1H), 6.88 (d, J = 2.2 Hz, 1H), 6.83 (dd, J = 8.2,
2.6 Hz, 1H), 5.42 (t, J = 9.3 Hz, 1H), 5.32 (t, J = 9.6 Hz, 1H), 5.25
(t, J = 9.5 Hz, 1H), 4.39 (d, J = 9.8 Hz, 1H), 4.21 (dd, J = 12.4, 1.9
Hz, 1H), 4.11 (dd, J = 12.5, 4.0 Hz, 1H), 3.85 (ddd, J = 9.7, 3.9, 1.9
Hz, 1H), 3.78 (s, 3H), 1.22 (s, 9H), 1.16 (s, 9H), 1.10 (s, 9H), 0.89
(s, 9H). 13C{1H} NMR (75 MHz, CDCl3): δ 178.0, 177.3, 176.4,
176.0, 159.5, 137.6, 129.3, 120.2, 114.8, 112.9, 80.8, 76.5, 73.7, 72.1,
67.9, 61.8, 55.2, 38.9, 38.8, 38.7, 38.5, 27.2, 27.09, 27.07, 27.0. IR
ATR ν (cm−1): 2975, 2873, 1734, 1615, 1588, 1482, 1461, 1398,
1367, 1269, 1174, 1154, 1134, 1095, 1077, 1040, 983, 939, 916, 890,
876, 786, 772, 761, 702. HRMS (EI) calcd for [C33H50O10 + H]
607.3477, found 607.3473.
2,3,4,6-Tetra-O-pivaloyl 1-(3-Toluyl)-1-deoxy-β-D-glucopyranose
1
(β-meta-22). H NMR (300 MHz, CDCl3): δ 7.24−7.15 (m, 1H),
7.12 (d, J = 6.5 Hz, 3H), 5.41 (t, J = 9.3 Hz, 1H), 5.32 (t, J = 9.5 Hz,
1H), 5.23 (t, J = 9.5 Hz, 1H), 4.37 (d, J = 9.8 Hz, 1H), 4.21 (dd, J =
12.4, 1.7 Hz, 1H), 4.11 (dd, J = 12.4, 3.9 Hz, 1H), 3.84 (ddd, J = 9.7,
3.8, 1.8 Hz, 1H), 2.30 (s, 3H), 1.22 (s, 9H), 1.16 (s, 9H), 1.10 (s,
9H), 0.88 (s, 9H). 13C{1H} NMR (75 MHz, CDCl3): δ 178.1, 177.3,
176.3, 176.0, 137.8, 136.0, 129.7, 128.3, 128.2, 124.9, 80.9, 76.5, 73.7,
72.2, 67.9, 61.8, 38.9, 38.72, 38.68, 38.5, 27.2, 27.08, 27.05, 26.9, 21.3.
HRMS (EI) calcd for [C33H50O9 + H] 591.3528, found 591.3524.
2,3,4,6-Tetra-O-pivaloyl 1-(4-Tolyl)-1-deoxy-β-D-glucopyranose
(β-para-22). The NMR spectral data match published data.3a
2,3,4,6-Tetra-O-pivaloyl 1-(2,4-Dimethylphenyl)-1-deoxy-β-D-glu-
1
copyranose (β-23). H NMR (300 MHz, CDCl3): δ 7.17 (d, J = 7.8
2,3,4,6-Tetra-O-pivaloyl 1-(2-Anisyl)-1-deoxy-β-D-glucopyranose
(β-para-6). The NMR spectral data match published data.3a
2,3,4,6-Tetra-O-pivaloyl 1-(2,6-Dimethoxyphenyl)-1-deoxy-β-D-
glucopyranose (β-18). The NMR spectral data match published
data.3a
Hz, 1H), 6.96 (d, J = 8.2 Hz, 1H), 6.93 (s, 1H), 5.52−5.37 (m, 2H),
5.31 (t, J = 9.5 Hz, 1H), 4.64 (d, J = 9.3 Hz, 1H), 4.19 (d, J = 12.3
Hz, 1H), 4.07 (dd, J = 12.4, 4.1 Hz, 1H), 3.85 (ddd, J = 10.0, 3.9, 1.5
Hz, 2H), 2.40 (s, 3H), 2.25 (s, 3H), 1.20 (s, 9H), 1.16 (s, 9H), 1.11
(s, 9H), 0.85 (s, 9H). 13C{1H} NMR (75 MHz, CDCl3): δ 178.0,
177.4, 176.4, 176.2, 138.4, 136.6, 131.4, 130.8, 127.7, 126.8, 77.7,
76.7, 74.0, 71.1, 67.9, 61.9, 38.8, 38.7, 38.4, 27.2, 27.07, 27.06, 26.8,
21.0, 19.4. HRMS (EI) calcd for [C34H52O9 + H] 605.3684, found
605.3682
2,3,4,6-Tetra-O-pivaloyl 1-(2,4-Dimethoxyphenyl)-1-deoxy-β-D-
1
glucopyranose (β-19). H NMR (300 MHz, CDCl3): δ 7.20 (d, J
= 8.5 Hz, 1H), 6.41 (dd, J = 8.5, 2.3 Hz, 1H), 6.30 (d, J = 2.3 Hz,
1H), 5.43−5.27 (m, 2H), 5.24 (t, J = 9.6 Hz, 1H), 4.85 (d, J = 9.0
Hz, 1H), 4.12 (dd, J = 12.4, 1.6 Hz, 1H), 4.02 (dd, J = 12.4, 3.8 Hz,
1H), 3.79 (ddd, J = 10.3, 3.7, 1.8 Hz, 1H), 3.71 (6H), 1.15 (s, 9H),
1.09 (s, 9H), 1.05 (s, 9H), 0.79 (s, 9H). 13C{1H} NMR (75 MHz,
CDCl3): δ 178.1, 177.3, 176.4, 176.3, 161.1, 158.5, 129.4, 116.8,
104.4, 98.2, 76.5, 74.0, 71.4, 68.0, 61.9, 55.3, 38.83, 38.71, 38.69, 38.5,
27.2, 27.1, 26.7. HRMS (EI) calcd for [C34H52O11 + H] 637.3582,
found 637.3576.
2,3,4,6-Tetra-O-pivaloyl 1-(Biphenyl-3-yl)-1-deoxy-β-D-glucopyr-
anose (α-meta-21). 1H NMR (300 MHz, CDCl3): δ 7.78−7.45
(m, 5H), 7.45−7.24 (m, 34), 5.70 (t, J = 8.7 Hz, 1H), 5.44−5.27 (m,
2H), 5.13 (t, J = 9.1 Hz, 1H), 4.09−3.92 (m, 2H), 3.71−3.59 (m,
1H), 1.11 (s, 9H), 1.06 (s, 9H), 1.04 (s, 9H), 0.97 (s, 9H). 13C{1H}
NMR (75 MHz, CDCl3): δ 178.0, 177.2, 177.0, 176.6, 141.6, 140.5,
136.0, 128.8, 127.5, 127.3, 127.02, 126.96, 73.6, 71.1, 70.4, 68.4, 62.3,
38.73, 38.67, 27.2, 27.1, 27.0, 26.9. HRMS (EI) calcd for [C38H52O9 +
H] 653.3684, found 653.3681.
2,3,4,6-Tetra-O-pivaloyl 1-(3,5-Dimethylphenyl)-1-deoxy-β-D-glu-
1
copyranose (β-24). H NMR (300 MHz, CDCl3): δ 7.02−6.71 (m,
3H), 5.40 (t, J = 9.2 Hz, 1H), 5.32 (t, J = 9.5 Hz, 1H), 5.21 (t, J = 9.5
Hz, 1H), 4.34 (d, J = 9.8 Hz, 1H), 4.22 (dd, J = 12.4, 1.7 Hz, 1H),
4.10 (dd, J = 12.4, 3.9 Hz, 1H), 3.83 (ddd, J = 9.6, 3.6, 1.7 Hz, 1H),
2.26 (s, 6H), 1.23 (s, 9H), 1.16 (s, 9H), 1.10 (s, 9H), 0.89 (s, 9H).
13C{1H} NMR (75 MHz, CDCl3): δ 178.1, 177.3, 176.3, 176.0, 137.7,
136.0, 130.5, 125.4, 80.9, 76.4, 73.8, 72.3, 67.9, 61.8, 38.9, 38.73,
38.69, 38.5, 27.2, 27.09, 27.06, 26.9, 21.2. HRMS (EI) calcd for
[C34H52O9 + H] 605.3684, found 605.3680.
2,3,4,6-Tetra-O-pivaloyl 1-(2-Thienyl)-1-deoxy-β-D-glucopyra-
nose (β-25). The NMR spectral data match published data.3a
2,3,4,6-Tetra-O-pivaloyl 1-(2-Thienyl)-1-deoxy-β-D-glucopyra-
nose (β-26). The compound could only be purified as a mixture
with its isomer β-25. Selected peaks for the product are described. 1H
NMR (300 MHz, CDCl3): δ 7.19−7.13 (m, 2H), 6.98 (dd, J = 4.4,
1.9 Hz, 1H), 5.27 (d, J = 9.2 Hz, 1H), 5.19 (t, J = 9.5 Hz, 1H), 5.17
(t, J = 9.5 Hz, 1H), 4.44 (d, J = 9.8 Hz, 1H), 4.09 (dd, J = 12.4, 1.8
Hz, 1H), 3.99 (dd, J = 12.4, 4.2 Hz, 1H), 3.73 (ddd, J = 10.0, 4.1, 1.9
Hz, 1H), 1.10 (s, 9H), 1.05 (s, 9H), 1.00 (s, 9H), 0.80 (s, 9H).
13C{1H} NMR (75 MHz, CDCl3): δ 178.1, 177.3, 176.3, 176.2, 137.2,
2,3,4,6-Tetra-O-pivaloyl 1-(Biphenyl-3-yl)-1-deoxy-β-D-glucopyr-
anose (β-meta-21). 1H NMR (300 MHz, CDCl3): δ 7.67−7.47
(m, 4H), 7.38 (dt, J = 19.6, 6.1 Hz, 5H), 5.55−5.29 (m, 3H), 4.50 (d,
J = 9.5 Hz, 1H), 4.25 (d, J = 11.8 Hz, 1H), 4.15 (dd, J = 12.4, 3.7 Hz,
1H), 3.89 (d, J = 8.4 Hz, 1H), 1.23 (s, 9H), 1.18 (s, 9H), 1.13 (s,
9H), 0.86 (s, 9H). 13C{1H} NMR (75 MHz, CDCl3): δ 177.7, 177.0,
176.0, 175.8, 141.1, 140.5, 136.4, 128.61, 128.58, 127.6, 127.2, 126.9,
126.4, 126.3, 124.6, 76.5, 76.4, 73.6, 71.7, 67.9, 61.8, 38.9, 38.8, 38.7,
I
J. Org. Chem. XXXX, XXX, XXX−XXX